Study highlights need for integration of policy, behavior change, and risk communication in pandemic response

FHS
July 27, 2023
12:05 pm

Researchers measured the association between reproduction number, a weekly measure of real-time severe acute respiratory syndrome coronavirus 2.

Tivdak gets primary endpoint in PhIII confirmatory study

Genmab and Seagen’s cervical cancer drug Tivdak has reached its primary endpoint in a confirmatory Phase III trial, and the results are expected to support

September 6, 2023

FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials”

September 19, 2024

Meta Title: “Forma Therapeutics Inc Files Patent for USP30 Inhibitor Compounds

Share this article According to GlobalData’s company profile on Forma Therapeutics, Cancer treatment biomarkers was a key innovation area identified from patents. Forma Therapeutics‘s grant

April 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.